[1] |
ZENG Xiaofan, XU Yiqi, LIU Shu, WU Qian, LI Zibao, HE Junjun, JIN Yuelong, ZHAO Yongli, HE Chunling, GAO Jialin.
Retrospectively analysis of the effect of low-dose aspirin on primary prevention of non-fatal myocardial infarction and cerebral infarction in patients with type 2 diabetes mellitus
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(6): 665-671.
|
[2] |
LU Xiya, LI Yuxing, LI Wenzhi, PENG Yuanyuan, HU Yi, WAN Li, CHEN Bilian.
Analysis of prescribing of antiplatelet drug in patients with coronary heart disease in department of geriatrics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2022, 27(11): 1285-1291.
|
[3] |
LI Lihua, ZHANG Shengpeng, QIN Jiaxu, NIAN Sihui.
Protective effects of the extract from Toona sinensis seeds on gastric mucosa injury in experimental mice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2021, 26(5): 546-551.
|
[4] |
ZHANG Haowen, ZHU Yejin, WU Xiang, CHEN Hanyu, SONG Yulei, BIAN Yaoyao, HAO Haiping, CHEN Xiaohu.
Study on high on-aspirin platelet reactivity in diabetic mice based on metabonomics
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2020, 25(3): 246-256.
|
[5] |
DANG Xiangji, ZHOU Lin, WANG Yixuan, ZENG Lu.
Individualized antithrombotic therapy on one patient with chronic renal insufficiency
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2017, 22(4): 477-480.
|
[6] |
LI Lin, ZHANG WEI, SHEN Chen-lin, ZHANG Ping, HUANG Xiao-hui.
Study of drug interaction between aspirin and warfarin in situ intestinal absorption model
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(5): 486-492.
|
[7] |
ZHANG Ping, SHEN Chen-lin, LI Lin, ZHANG Wei, YAO Cheng-zeng, HUANG Xiao-hui.
Inhibitory effect of aspirin on the expression of MMP-9 and its mechanism in LPS-induced RAW264.7 cells
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(4): 388-393.
|
[8] |
LI Wei-hong, LI Bin.
Effects of aspirin on inflammatory responses in PCOS rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2015, 20(1): 19-23.
|
[9] |
XIE Hao, ZHU Yu-mei, HAO Hai-ping, ZHENG Xiao, MA Si-jing, WANG Guang-ji.
Research progress of aspirin resistance in diabetic statue
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(2): 233-240.
|
[10] |
YAN Fu-qin, FAN Zhen.
Improve and correct the Clinical Guide to Platelet Aggregation Inhibitors for no-cardiac surgery
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2014, 19(12): 1352-1355.
|
[11] |
YUN Wen-bo1, JIANG Peng-li1, WU Jing1, SUN He1,2.
Bleeding risk is higher when warfarin used alone compared to the associated use of aspirin with clopidogrel
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2013, 18(11): 1251-1259.
|
[12] |
HUANG Xiao-hui, WANG Xia-qin, TANG Hai-qin, WANG Qin, CHEN Yun, LI Jing, LI Jun.
Pharmacokinetic interaction between warfarin and aspirin in rats
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2012, 17(2): 189-194.
|
[13] |
MAO Xin-lei, HAN Li-ya, HUANG Xiang-dong, GUAN Chao-hong, YAN Xue-qin, CHEN Wei-dong.
Analysis on the influencing factors of cerebral infarction patients with aspirin prevention failure
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2010, 15(10): 1148-1151.
|
[14] |
PU Qi-song, ZHENG Qian, ZHANG Jian-wu.
Inhibitory effect of aspirin-niacinamide-zinc complex on human gastric carcinoma cell line SGC-7901
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1091-1094.
|
[15] |
SUN An-xiu, LIU Yang-chen, GU Ling, LV Jian-feng, FAN Hui, SHI Ai-ping, WANG Lin.
Intervention study on compliance of aspirin in clinical practice
[J]. Chinese Journal of Clinical Pharmacology and Therapeutics, 2009, 14(10): 1156-1159.
|